Clinical Neurology · Neuro-Immunology
Neuro-Immunology
Neural antibodies, autoimmune encephalitis, immunomodulators, and MS disease-modifying therapy.
Autoimmune EncephalitisDefinitions, classification, diagnostic criteria, workup, and treatment.Open →
Neuronal Surface AntibodiesCell-membrane and synaptic antibodies — channels, receptors, adhesion proteins.Open →
Intracellular / Onconeuronal AntibodiesClassic paraneoplastic nuclear and cytoplasmic antibodies.Open →
Antibody PanelsCommercial autoimmune and paraneoplastic testing panels.Open →
Clinical SyndromesAntibody clinical profiles and a syndrome-by-symptom approach.Open →
ImmunomodulatorsAgents by class — mechanism, dose, side effects, and monitoring.Open →
Choosing an ImmunomodulatorAgent selection by disease and pregnancy class.Open →
Rituximab ProtocolIndications, screening, premedication, and infusion protocol.Open →
MS DMT Efficacy & PML RiskDMT efficacy tiers and JCV/PML risk stratification.Open →Related medications
Neuropharmacology handouts relevant to neuro-immunology.
MS Disease-Modifying TherapiesMS DMTs — dose, mechanism, side effects, and monitoring.Open →
NMOSD & MOGAD TreatmentAQP4-NMOSD and MOGAD — approved and off-label therapies, mechanism, and clinical tips.Open →
MS vs NMOSD vs MOGADSide-by-side comparison — antibody, MRI, CSF, course, and treatment.Open →
MS Symptomatic ManagementSpasticity, gait, fatigue, mood, pain, bladder — practical symptom control in MS.Open →